How Liraglutide is Administered
Liraglutide is administered as a once-daily subcutaneous injection 1.
Route and Frequency
- Subcutaneous injection is the standard route of administration
- Once daily dosing provides 24-hour glycemic coverage 2
- The injection can be given at any time of day, independent of meals
- No dose adjustment needed based on renal or hepatic function for the approved diabetes doses 3
Dosing Regimen
The medication follows a structured titration schedule to minimize gastrointestinal side effects 1:
- Start at 0.6 mg daily for the first week (this is NOT an effective therapeutic dose, only for tolerability)
- Increase to 1.2 mg daily after 1 week
- May further increase to 1.8 mg daily if additional glycemic control is needed 4, 5
The slow weekly titration is specifically designed to reduce nausea and improve patient tolerability 6, 4.
Injection Sites and Technique
- Administered via subcutaneous injection into the abdomen, thigh, or upper arm
- Drug exposure is largely independent of injection site 2
- Patients self-administer using a pre-filled pen device 4
Important Clinical Considerations
The 0.6 mg starting dose is not effective for glycemic control and serves only to reduce gastrointestinal intolerance during initiation 1. All patients should be titrated to at least 1.2 mg for therapeutic effect.
The once-daily dosing is enabled by liraglutide's pharmacokinetic properties, including slowed release from the injection site and reduced elimination rate, which provide sustained 24-hour drug exposure 2.
While an oral formulation has been explored in research settings 7, 8, only the subcutaneous formulation is currently FDA-approved and available for clinical use 1.